In this authoritative volume you'll find today's most important molecular neurobiological advances and their relevance to clinicians treating patients with mental illness. Molecular Neurobiology for the Clinician, Review of Psychiatry, Volume 22 updates the latest findings - and their impact on psychiatry.
Über den Autor
Dennis S. Charney, M.D., is Chief of the Mood and Anxiety Disorders Program, and Chief of the Experimental Therapeutics and Pathophysiology Branch, at the National Institute of Mental Health in Bethesda, Maryland.
Inhaltsverzeichnis
Molecular neurobiology of childhood- and adolescent-onset psychiatric disorders. Molecular genetics: a role in diagnosis and treatment of psychiatric disorders? Molecular neurobiology and schizophrenia: implications for etiology and treatment. Molecular mechanisms of drug addiction. Cellular neurobiology of severe mood and anxiety disorders: implications for development of novel therapeutics. Index.
Klappentext
This book discusses discoveries that have the potential to revolutionize your clinical approach by changing the ways in which you diagnose and treat patients. Clinicians will learn about the effects on psychiatry of advances in the molecular basis of neuronal network function and the identification of novel molecular targets for drug development.rn